LAS VEGAS--(BUSINESS WIRE)--Women 16 to 20 years of age are just as likely to have significant cervical disease as women 21 and older, according to results of a U.S. Food and Drug Administration (FDA) pivotal clinical trial of the Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) LightTouch™ Cervical Scanner, being presented at the American Society for Colposcopy and Cervical Pathology biennial meeting.
